0 ASM Microbe: Genetic analysis used to show transfer of carbapenem resistance
Whole-genome sequencing has been used to demonstrate that carbapenem resistance can be transferred among unrelated bacteria species in a healthcare setting.
Browsing: Clinical > Clinical Diseases
0 Pediatric multi-drug resistant infections increasing in the USA
Trends in Acinetobacter baumannii infections, one of the most prevalent hospital-acquired infections in children, have been studied revealing that both cephalosporin and carbapenem resistance has increased.
0 International Nurses Day: A day in the life of… Helen Bosley, Infection Prevention and Control Matron
To celebrate International Nurses Day we spoke to Helen Bosley, Infection Prevention and Control Matron at Oxford Health NHS Foundation Trust about her responsibilities, her daily routine and her hobbies.
0 International Nurses Day: A day in the life of… Leila Hail, Senior Clinical Nurse Specialist in Infection Control
With May 12 marking International Nurses Day we spoke to Leila Hail, Senior Clinical Nurse Specialist in Infection Control at University College Hospital, about her responsibilities, the challenges she faces and an incident involving alcohol gel!
0 ECCMID18: Additional precautions by healthcare workers might not prevent the spread of ESBL-producing Enterobacteriaceae
Using contact precautions in addition the to the basic level of infection control might not limit the spread of drug-resistant Enterobacteriaceae, according to work presented at ECCMID.
0 N-TB – first-of-kind app launched for nutritional assessment and counselling of tuberculosis patients
World TB Day has seen the launch of the N-TB app, a first-of-kind tool to help healthcare providers in the nutritional assessment and counselling of adult patients with tuberculosis.
0 New estimates for England suggest 20% of antibiotic prescribing is inappropriate
Recent research by Public Health England estimates that over 20% of all antibiotic prescriptions written in England primary care centers could be avoided.
0 Microbiome therapeutics – the pipeline for C. difficile infection
We take a look at the key microbiome therapeutics currently in the clinical pipeline for recurrent C. difficile infections and their prospects for the treatment of this disease in the future.
1 Infographic: The microbiome and infectious diseases
In our latest infographic we provide a visual snapshot of the infections and immune processes that have been linked with the microbiome thus far, explaining some of the evidence
0 Synergistic and antibiofilm properties of ocellatin peptides against multidrug-resistant Pseudomonas aeruginosa
In this article, the authors test ocellatin peptides against one of the most concerning priority pathogens, Pseudomonas aeruginosa.
